Semler Scientific's Q2 Revenue Jumps 26%, Bitcoin Holdings Grow
| Field | Detail |
|---|---|
| Company | Semler Scientific, Inc. |
| Form Type | 10-Q |
| Filed Date | Aug 4, 2025 |
| Risk Level | high |
| Sentiment | mixed |
Sentiment: mixed
Topics: Medical Devices, Cardiovascular Diagnostics, Bitcoin Investment, Q2 Earnings, Revenue Growth, Net Income Growth, Market Risk
TL;DR
**Semler's Q2 numbers look solid, but their Bitcoin bet is a wild card that could either pay off big or burn them.**
AI Summary
Semler Scientific, Inc. reported a significant increase in revenue for the three months ended June 30, 2025, reaching $17.5 million, up from $13.9 million in the prior year, representing a 25.9% increase. Net income for the quarter also saw a substantial rise to $4.2 million, or $0.50 per diluted share, compared to $2.8 million, or $0.34 per diluted share, in the same period of 2024. For the six months ended June 30, 2025, total revenue was $33.1 million, an increase from $27.4 million in the first half of 2024. Net income for the six-month period was $7.8 million, or $0.93 per diluted share, up from $5.3 million, or $0.64 per diluted share, in the previous year. A key strategic change is the company's continued investment in Bitcoin, holding 828 bitcoins as of June 30, 2025, with a carrying value of $54.4 million. This Bitcoin investment introduces significant market risk due to price volatility. The company's strategic outlook emphasizes growth in its core cardiovascular diagnostic products while diversifying its asset base with Bitcoin.
Why It Matters
Semler Scientific's strong revenue and net income growth, coupled with its aggressive Bitcoin investment strategy, presents a mixed bag for investors. While the core diagnostic business shows healthy expansion, the substantial allocation to Bitcoin introduces a new layer of volatility and speculative risk, potentially impacting shareholder value. This move could attract a new class of investors interested in crypto exposure, but it also alienates traditional healthcare investors seeking stable growth. Competitively, this diversification could either be a genius move to hedge against inflation and traditional market risks or a distraction from its core medical device focus, potentially allowing competitors to gain ground in the cardiovascular diagnostics market.
Risk Assessment
Risk Level: high — The company's significant investment in Bitcoin, holding 828 bitcoins with a carrying value of $54.4 million as of June 30, 2025, introduces substantial market risk. Bitcoin's price is highly volatile, and a significant downturn could materially impact Semler Scientific's financial position and results of operations, as noted in the filing.
Analyst Insight
Investors should carefully evaluate Semler Scientific's dual strategy: strong performance in its core medical diagnostics business versus the high-risk, high-reward Bitcoin investment. Consider if the potential upside from Bitcoin outweighs the increased volatility and if the company's core business can sustain growth independently of crypto fluctuations.
Financial Highlights
- revenue
- $17.5M
- net Income
- $4.2M
- eps
- $0.50
- revenue Growth
- +25.9%
Revenue Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Cardiovascular Diagnostic Products | $17.5M | +25.9% |
Key Numbers
- $17.5M — Q2 2025 Revenue (Up 25.9% from $13.9M in Q2 2024)
- $4.2M — Q2 2025 Net Income (Increased from $2.8M in Q2 2024)
- $0.50 — Q2 2025 Diluted EPS (Up from $0.34 in Q2 2024)
- 828 — Bitcoins Held (As of June 30, 2025, representing a significant asset diversification)
- $54.4M — Bitcoin Carrying Value (As of June 30, 2025, highlighting exposure to crypto volatility)
- $33.1M — Six-Month 2025 Revenue (Increased from $27.4M in the first half of 2024)
- $7.8M — Six-Month 2025 Net Income (Up from $5.3M in the first half of 2024)
Key Players & Entities
- Semler Scientific, Inc. (company) — filer of the 10-Q
- $17.5 million (dollar_amount) — total revenue for Q2 2025
- $13.9 million (dollar_amount) — total revenue for Q2 2024
- $4.2 million (dollar_amount) — net income for Q2 2025
- $2.8 million (dollar_amount) — net income for Q2 2024
- $0.50 (dollar_amount) — diluted EPS for Q2 2025
- $0.34 (dollar_amount) — diluted EPS for Q2 2024
- 828 (dollar_amount) — number of bitcoins held as of June 30, 2025
- $54.4 million (dollar_amount) — carrying value of Bitcoin as of June 30, 2025
- Bitcoin (other) — digital asset investment
FAQ
What were Semler Scientific's revenues for the second quarter of 2025?
Semler Scientific's revenues for the three months ended June 30, 2025, were $17.5 million, marking a 25.9% increase from $13.9 million in the same period of 2024.
How much net income did Semler Scientific report in Q2 2025?
For the second quarter of 2025, Semler Scientific reported a net income of $4.2 million, or $0.50 per diluted share, compared to $2.8 million, or $0.34 per diluted share, in Q2 2024.
What is Semler Scientific's strategy regarding Bitcoin?
Semler Scientific has strategically invested in Bitcoin, holding 828 bitcoins with a carrying value of $54.4 million as of June 30, 2025, as part of its asset diversification strategy.
What are the risks associated with Semler Scientific's Bitcoin investment?
The primary risk is the high volatility of Bitcoin's price, which could significantly impact Semler Scientific's financial position and operating results due to potential impairment charges or market value fluctuations.
How has Semler Scientific's revenue performed year-to-date in 2025?
For the six months ended June 30, 2025, Semler Scientific's total revenue was $33.1 million, an increase from $27.4 million reported for the same period in 2024.
What is the diluted earnings per share for Semler Scientific for the first half of 2025?
Semler Scientific's diluted earnings per share for the six months ended June 30, 2025, was $0.93, up from $0.64 per diluted share in the first half of 2024.
Why did Semler Scientific invest in Bitcoin?
Semler Scientific invested in Bitcoin as a strategic move to diversify its asset base and potentially hedge against inflation, as indicated by its substantial holdings.
What impact does Bitcoin volatility have on Semler Scientific's financials?
Bitcoin's price volatility can lead to significant fluctuations in the carrying value of Semler Scientific's Bitcoin holdings, potentially resulting in impairment charges or gains that affect net income.
What is Semler Scientific's core business?
Semler Scientific's core business focuses on developing and marketing innovative products and services for the diagnosis and treatment of chronic diseases, primarily in cardiovascular diagnostics.
Should investors be concerned about Semler Scientific's Bitcoin holdings?
Investors should be aware that while Semler Scientific's core business is growing, the substantial Bitcoin holdings introduce a high level of market risk and volatility, which could impact the company's overall financial stability and stock performance.
Risk Factors
- Bitcoin Price Volatility [high — market]: The company holds 828 bitcoins with a carrying value of $54.4 million as of June 30, 2025. The significant price volatility of Bitcoin introduces substantial market risk and potential for material adverse impact on the company's financial position and results of operations.
- Cryptocurrency Regulatory Uncertainty [medium — regulatory]: The regulatory landscape for cryptocurrencies is evolving and uncertain. Changes in regulations could impact the company's ability to hold, transact, or realize the value of its Bitcoin holdings, potentially affecting its business strategy and financial performance.
- Dependence on Key Products [medium — operational]: While diversifying with Bitcoin, the company's core business relies on cardiovascular diagnostic products. Any disruption in the development, manufacturing, sales, or adoption of these products could negatively impact revenue and profitability.
- Valuation of Digital Assets [high — financial]: The carrying value of Bitcoin is subject to fair value adjustments, which can lead to significant unrealized gains or losses. This introduces volatility into the company's financial statements that is not directly tied to its core operating business.
Industry Context
Semler Scientific operates in the medical device sector, specifically focusing on cardiovascular diagnostic products. The industry is characterized by innovation, regulatory oversight, and competition from established players and emerging technologies. The company's strategic diversification into Bitcoin represents a significant departure from traditional medical device industry norms.
Regulatory Implications
As a medical device company, Semler Scientific is subject to regulations from bodies like the FDA. The company's significant Bitcoin holdings also expose it to evolving cryptocurrency regulations, which could impact its financial reporting and operational flexibility.
What Investors Should Do
- Monitor Bitcoin price volatility and its impact on Semler Scientific's financial statements.
- Analyze the growth drivers of the core cardiovascular diagnostic products segment.
- Evaluate the company's strategy for managing its Bitcoin asset, including any hedging or disposal plans.
Key Dates
- 2025-06-30: Quarter End and Reporting Date — Marks the end of the second fiscal quarter and the period for which financial results are reported, including the company's Bitcoin holdings.
- 2025-08-04: 10-Q Filing Date — The date Semler Scientific, Inc. filed its quarterly report (10-Q) for the period ending June 30, 2025, providing detailed financial and operational information to investors.
Glossary
- Diluted EPS
- Earnings per share calculated by dividing net income by the total number of diluted shares outstanding. It accounts for all potential dilutive common shares, such as stock options and convertible securities. (Indicates the profitability of the company on a per-share basis, reflecting the impact of all potential shares.)
- Carrying Value
- The value of an asset as recorded on a company's balance sheet. For Bitcoin, this may differ from its market value due to accounting treatment. (Shows the book value of the company's Bitcoin holdings, which is subject to change based on accounting rules and market fluctuations.)
- 10-Q
- A quarterly report required by the U.S. Securities and Exchange Commission (SEC) that provides a continuing view of the company's financial position during the year. (The primary document for investors to review a company's performance and financial health between annual reports.)
Year-Over-Year Comparison
Semler Scientific has demonstrated robust year-over-year growth, with Q2 2025 revenue up 25.9% to $17.5 million and net income rising to $4.2 million. This contrasts with the previous year's performance, highlighting strong operational execution in its core business. A key development since the last filing is the significant increase in its Bitcoin holdings, now valued at $54.4 million, introducing a new layer of market risk and strategic complexity not present in prior periods.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on August 4, 2025 regarding Semler Scientific, Inc..